{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:08:12Z","timestamp":1790701692730,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008680","name":"Mallinckrodt Pharmaceuticals USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpet.2026.105011","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:59:26Z","timestamp":1786978766000},"page":"105011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["BE2012 a novel, REV-ERB antagonist that promotes regenerative myogenesis in vivo with substantially improved pharmacokinetics relative to SR8278"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2309-6933","authenticated-orcid":false,"given":"Isabelle","family":"Cote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore C.","family":"Valfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4864-7113","authenticated-orcid":false,"given":"Ryan K.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2229-1071","authenticated-orcid":false,"given":"Sheryl L.","family":"Burris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7117-5107","authenticated-orcid":false,"given":"Matthew E.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingaiah","family":"Maram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4800-7976","authenticated-orcid":false,"given":"Bahaa","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2922-4449","authenticated-orcid":false,"given":"Thomas P.","family":"Burris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jpet.2026.105011_bib1","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1152\/japplphysiol.00570.2009","article-title":"Rev-erb-\u03b1: an integrator of circadian rhythms and metabolism","volume":"107","author":"Duez","year":"2009","journal-title":"J Appl Physiol (1985)"},{"issue":"7","key":"10.1016\/j.jpet.2026.105011_bib2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/me.2007-0519","article-title":"Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock","volume":"22","author":"Burris","year":"2008","journal-title":"Mol Endocrinol"},{"issue":"18","key":"10.1016\/j.jpet.2026.105011_bib3","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1093\/nar\/24.18.3481","article-title":"Transcriptional repression by the orphan steroid receptor RVR\/Rev-erb beta is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis","volume":"24","author":"Burke","year":"1996","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.jpet.2026.105011_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1021\/cb1002575","article-title":"Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB","volume":"6","author":"Kojetin","year":"2011","journal-title":"ACS Chem Biol"},{"issue":"7396","key":"10.1016\/j.jpet.2026.105011_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature11030","article-title":"Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists","volume":"485","author":"Solt","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpet.2026.105011_bib6","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1038\/s41467-022-34892-4","article-title":"Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB","volume":"13","author":"Murray","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.jpet.2026.105011_bib7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nm.3213","article-title":"Rev-erb-\u03b1 modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy","volume":"19","author":"Woldt","year":"2013","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jpet.2026.105011_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227720","article-title":"Rev-erb\u03b1 heterozygosity produces a dose-dependent phenotypic advantage in mice","volume":"15","author":"Welch","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpet.2026.105011_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17496-7","article-title":"Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle","volume":"7","author":"Welch","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jpet.2026.105011_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.molmet.2017.05.001","article-title":"Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome","volume":"6","author":"Welch","year":"2017","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.jpet.2026.105011_bib11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41467-021-21477-w","article-title":"Dysregulation of REV-ERB\u03b1 impairs GABAergic function and promotes epileptic seizures in preclinical models","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.jpet.2026.105011_bib12","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1111\/febs.16601","article-title":"Drugging the circadian clock feedback cycle to ameliorate cartilage degeneration","volume":"289","author":"He","year":"2022","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.jpet.2026.105011_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s13311-022-01215-w","article-title":"Pharmacological rescue with SR8278, a circadian nuclear receptor REV-ERB\u03b1 antagonist as a therapy for mood disorders in Parkinson\u2019s disease","volume":"19","author":"Kim","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.jpet.2026.105011_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/acs.jmedchem.3c01432","article-title":"Identification of a dual autophagy and REV-ERB inhibitor with in vivo anticancer efficacy","volume":"67","author":"Palomba","year":"2024","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.jpet.2026.105011_bib15","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s43587-025-00950-x","article-title":"REV-ERB\u03b1 regulates brain NAD+ levels and tauopathy via an NFIL3-CD38 axis","volume":"5","author":"Lee","year":"2025","journal-title":"Nat Aging"},{"issue":"2","key":"10.1016\/j.jpet.2026.105011_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115273","article-title":"Rev-erb-\u03b1 antagonism in alveolar macrophages protects against pneumococcal infection in elderly mice","volume":"44","author":"Silva Angulo","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.jpet.2026.105011_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jot.2025.06.005","article-title":"Inhibiting the REV-ERBalpha expression protects against mechanical overloading-induced cartilage clock disruption and osteoarthritis progression","volume":"53","author":"Xu","year":"2025","journal-title":"J Orthop Translat"},{"issue":"1","key":"10.1016\/j.jpet.2026.105011_bib18","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1038\/s41598-019-41059-7","article-title":"The nuclear receptor and clock repressor Rev-erbalpha suppresses myogenesis","volume":"9","author":"Chatterjee","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jpet.2026.105011_bib19","first-page":"439","article-title":"Discovery of BE2012, a first-in-class REV-ERBalpha\/beta antagonist with favorable selectivity and pharmacokinetics, and in vivo efficacy in inducing key myogenic factors for muscle repair upon acute muscle injury","volume":"69","author":"Maram","year":"2026","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.jpet.2026.105011_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.565","article-title":"Modulating myogenesis: an optimized in vitro assay to pharmacologically influence primary myoblast differentiation","volume":"2","author":"VanGenderen","year":"2022","journal-title":"Curr Protoc"},{"issue":"5","key":"10.1016\/j.jpet.2026.105011_bib21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.stem.2013.07.016","article-title":"Myf5-positive satellite cells contribute to Pax7-dependent long-term maintenance of adult muscle stem cells","volume":"13","author":"G\u00fcnther","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jpet.2026.105011_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jchromb.2016.03.033","article-title":"A validated ultra-performance liquid chromatography-tandem mass spectrometry method to identify the pharmacokinetics of SR8278 in normal and streptozotocin-induced diabetic rats","volume":"1020","author":"Dong","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"10.1016\/j.jpet.2026.105011_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/ml500146d","article-title":"Validity of ligand efficiency metrics","volume":"5","author":"Murray","year":"2014","journal-title":"ACS Med Chem Lett"},{"issue":"Pt 6","key":"10.1016\/j.jpet.2026.105011_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1242\/jcs.111.6.769","article-title":"Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates \u201creserve cells\u201d","volume":"111","author":"Yoshida","year":"1998","journal-title":"J Cell Sci"},{"issue":"21","key":"10.1016\/j.jpet.2026.105011_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113380","article-title":"Skeletal muscle regeneration in cardiotoxin-induced muscle injury models","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.105011_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00043.2011","article-title":"Satellite cells and the muscle stem cell niche","volume":"93","author":"Yin","year":"2013","journal-title":"Physiol Rev"},{"issue":"24","key":"10.1016\/j.jpet.2026.105011_bib27","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1093\/hmg\/ddt341","article-title":"Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-\u03b12 chain-null congenital muscular dystrophy mice","volume":"22","author":"Aoki","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpet.2026.105011_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fcell.2020.00267","article-title":"Methods for accurate assessment of myofiber maturity during skeletal muscle regeneration","volume":"8","author":"Yoshimoto","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.jpet.2026.105011_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10974-020-09584-5","article-title":"Cardiotoxin-induced skeletal muscle injury elicits profound changes in anabolic and stress signaling, and muscle fiber type composition","volume":"41","author":"Dalle","year":"2020","journal-title":"J Muscle Res Cell Motil"},{"issue":"2","key":"10.1016\/j.jpet.2026.105011_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/muscles2020011","article-title":"The role of mitochondria in mediation of skeletal muscle repair","volume":"2","author":"Alway","year":"2023","journal-title":"Muscles"},{"issue":"5","key":"10.1016\/j.jpet.2026.105011_bib31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/cells12050716","article-title":"The role of mitophagy in skeletal muscle damage and regeneration","volume":"12","author":"Chatzinikita","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.jpet.2026.105011_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196787","article-title":"Distinct roles for REV-ERBalpha and REV-ERBbeta in oxidative capacity and mitochondrial biogenesis in skeletal muscle","volume":"13","author":"Amador","year":"2018","journal-title":"PLoS One"},{"issue":"Pt 7","key":"10.1016\/j.jpet.2026.105011_bib33","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1113\/jphysiol.2011.205658","article-title":"Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase\/Akt signalling","volume":"589","author":"Miyazaki","year":"2011","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105011_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13078","article-title":"Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease","volume":"19","author":"Lee","year":"2020","journal-title":"Aging Cell"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:44:49Z","timestamp":1790700289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526012115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022356526012115"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105011","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BE2012 a novel, REV-ERB antagonist that promotes regenerative myogenesis in vivo with substantially improved pharmacokinetics relative to SR8278","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105011"}}